Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,908 | 5,004 | 6,041 | 3,535 | 5,167 |
| Marketable Securities | N/A | 0 | 2,303 | 8,512 | 11,113 |
| Other current assets | 258 | 324 | 248 | 77 | 0 |
| TOTAL | $2,938 | $6,490 | $10,134 | $14,070 | $17,214 |
| Non-Current Assets | |||||
| PPE Net | 4 | 6 | 8 | 11 | 14 |
| Other Non-Current Assets | 33 | 33 | 33 | 33 | 33 |
| TOTAL | $37 | $39 | $41 | $44 | $47 |
| Total Assets | $2,975 | $6,529 | $10,175 | $14,114 | $17,261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 312 | 401 | 312 | 310 | 532 |
| Accrued Expenses | 569 | 603 | 550 | 906 | 543 |
| TOTAL | $1,211 | $1,425 | $1,393 | $1,614 | $1,485 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,211 | $1,425 | $1,393 | $1,614 | $1,485 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,545 | 26,545 | 26,545 | 26,545 | 26,545 |
| Common Shares | 265 | 265 | 265 | 265 | 265 |
| Retained earnings | -289,841 | -286,305 | -282,421 | -278,463 | -275,010 |
| TOTAL | $1,764 | $5,104 | $8,782 | $12,500 | $15,776 |
| Total Liabilities And Equity | $2,975 | $6,529 | $10,175 | $14,114 | $17,261 |